v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities . Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Vaxcyte-related accrual under Vaxcyte Supply Agreement

 

$

7,375

 

 

$

6,933

 

CMO-related accrual

 

 

6,934

 

 

 

8,195

 

Clinical trials-related accrual

 

 

4,865

 

 

 

4,283

 

Tax and related expenses

 

 

15,165

 

 

 

15,165

 

Other

 

 

3,407

 

 

 

3,897

 

Total accrued expenses and other current liabilities

 

$

37,746

 

 

$

38,473